Clinical profile of cutaneous adverse effects of epidermal growth factor receptor inhibitors: A prospective observational study of 76 cases

Background: Epidermal growth factor receptor (EGFR) inhibitors are an extensively utilized class of chemotherapeutic agents which form an integral component of treatment in solid organ malignancies such as non-small-cell lung carcinoma, pancreatic carcinoma, colorectal carcinoma, and head and neck c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Neerja Saraswat (Author), Aradhana Sood (Author), Dharmesh Kumar (Author), Rajesh Verma (Author), Kumar Sushil (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nail changes induced by chemotherapeutic agents
by: Neerja Saraswat, et al.
Published: (2020)

Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
by: K. Chanprapaph, et al.
Published: (2014)

Recurrent urinary retention: An unusual presentation of laryngo-onycho-cutaneous syndrome
by: Aradhana Sood, et al.
Published: (2020)

A descriptive study to analyze chemotherapy-induced hair loss and its psychosocial impact in adults: Our experience from a tertiary care hospital
by: Neerja Saraswat, et al.
Published: (2019)

Dermatological side effects of epidermal growth factor receptor inhibitors: 'Pride' complex
by: Bhushan Madke, et al.
Published: (2014)

Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
by: Philomena Charlotte Dsouza, et al.
Published: (2017)

The epidermal growth pattern in human fetuses
by: Shivani Dhingra, et al.
Published: (2020)

Orofacial pigmentary lesions in the pediatric age group: A descriptive observational study
by: Neerja Saraswat, et al.
Published: (2020)

Six cases of purpuric eruptions induced by epidermal growth factor receptor inhibitors
by: Tomoko Hiraiwa, et al.
Published: (2018)

The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer
by: Ashwaq Al Olayan, et al.
Published: (2012)

Adverse event profiles of epidermal growth factor receptor‐tyrosine kinase inhibitors in cancer patients: A systematic review and meta‐analysis
by: Xiaonan Yin, et al.
Published: (2021)

Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
by: Junichi Hachisuka, et al.
Published: (2011)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Giuliano Palumbo, et al.
Published: (2020)

Reacções cutâneas adversas aos inibidores do receptor do factor de crescimento epidérmico: estudo de 14 doentes Adverse cutaneous reactions to epidermal growth factor receptor inhibitors: a study of 14 patients
by: Felicidade Santiago, et al.
Published: (2011)

An observational study to describe the clinical pattern of dermatological emergencies from emergency department and intensive care unit: Our experience from a tertiary care hospital in Northern India
by: Debdeep Mitra, et al.
Published: (2019)

Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020)

Expression of breast cancer type 1 and its relation with expression of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2/neu in breast carcinoma on trucut biopsy specimens
by: Deepti Verma, et al.
Published: (2018)

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations
by: Nikolova Dafina, et al.
Published: (2022)

The "String of Pearls" Sign of Chronic Bullous Disease of Childhood (CBDC)
by: Durga M. Tripathy, et al.
Published: (2024)

Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
by: Beatrice Copps, BSc, et al.
Published: (2020)

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging
by: Israa eAbdelrahman, et al.
Published: (2014)

Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
by: Katsuhiro Masago, et al.
Published: (2018)

A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma
by: Ying Jiang, et al.
Published: (2023)

Epidermal growth factor receptor: Role in human cancer
by: Prashanth Rajaram, et al.
Published: (2017)

Modulation of Pathological Pain by Epidermal Growth Factor Receptor
by: Jazlyn P. Borges, et al.
Published: (2021)

Folliculitis Decalvans Due to Epidermal Growth Factor Inhibitor
by: Aurora Maria Alessandrini, et al.
Published: (2024)

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
by: Zhang H
Published: (2016)

Pigmentary adverse effects of chemotherapeutic agents
by: Neerja Saraswat, et al.
Published: (2019)

Transcriptional effects of inhibiting epidermal growth factor receptor in keratinocytes
by: Alix Gazel, et al.
Published: (2013)

Nuclear epidermal growth factor receptor as a therapeutic target
by: Benjamin Atwell, et al.
Published: (2023)

A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin)
by: Neerja Saraswat, et al.
Published: (2023)

A systematic review of epidermal growth factor receptor tyrosine kinase inhibitor-induced heart failure and its management
by: Mohammad Nawaf AlShatnawi, et al.
Published: (2022)

Evaluation of human epidermal growth factor receptor 2 expression in colorectal cancer and its correlation with clinicopathological variables
by: Sana Ahuja, et al.
Published: (2021)

The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect
by: Eirini Kostopoulou, et al.
Published: (2018)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
by: Sathishbabu Paranthaman, et al.
Published: (2020)

Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia
by: Karina J. Cancel-Artau, MD, et al.
Published: (2024)

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients
by: Ji Su Lee, et al.
Published: (2024)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
by: Hyung Kyu Park, et al.
Published: (2017)

Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
by: Rancés Blanco, et al.
Published: (2017)

Acute methotrexate toxicity presenting as ulcers in plaques of psoriasis vulgaris
by: Anuj Bhatnagar, et al.
Published: (2015)